未登录

H

Hsien-Yen Chang

Johns Hopkins University

H指数:38

被引数:5,403

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

County-Level Factors Associated with Reversal of Insurer-Approved HIV Pre-Exposure Prophylaxis Prescriptions in the United States, 2018

2018年美国县级因素与承保人批准的HIV暴露前预防处方逆转的相关性研究

AIDS AND BEHAVIOR

IF2.4

2024-12-300

PRE

Estimating The Impact Of Out-OfPocket Cost Changes On Abandonment Of HIV PreExposure Prophylaxis

IF8.1

2024-01-018

OA

Risk of Major Bleeding Associated with Concomitant Direct-Acting Oral Anticoagulant and Clopidogrel Use: A Retrospective Cohort Study

IF3.8

2023-12-231

PRE

Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic A Multilevel Framework

IF2.8

2022-12-062

OA

Claims-based pharmacy markers for comprehensive medication management program case identification: Validation against concurrent and prospective healthcare costs and utilization

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY

IF2.8

2022-10-012

PRE

Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic

JOURNAL OF ADOLESCENT HEALTH

IF4.5

2022-08-017

OAAI

Improving the Prediction of Persistent High Health Care Utilizers: Retrospective Analysis Using Ensemble Methodology

JMIR MEDICAL INFORMATICS

IF3.8

2022-03-241

OAAI

Assessing the Value of Unsupervised Clustering in Predicting Persistent High Health Care Utilizers: Retrospective Analysis of Insurance Claims Data

JMIR MEDICAL INFORMATICS

IF3.8

2021-11-252

OAAI

Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study

SCIENTIFIC REPORTS

IF3.9

2021-08-173

OAAI

Novel population-level proxy measures for suboptimal HIV preexposure prophylaxis initiation and persistence in the USA

IF3.1

2021-07-1619

OA

Differential impact of mitigation policies and socioeconomic status on COVID-19 prevalence and social distancing in the United States

BMC PUBLIC HEALTH

IF3.6

2021-06-1430

OAAI

Early relaxation of community mitigation policies and risk of COVID-19 resurgence in the United States

PREVENTIVE MEDICINE

IF3.2

2021-04-019

OAAI

Association of antidiabetic therapies with lower extremity amputation, mortality and healthcare cost from a nationwide retrospective cohort study in Taiwan

SCIENTIFIC REPORTS

IF3.9

2021-03-267

OAAI

Assessing the association between area deprivation index on COVID-19 prevalence: a contrast between rural and urban U.S. jurisdictions

AIMS PUBLIC HEALTH

IF2.7

2021-01-0122

OAAI

External Validation of and Factors Associated with the Overuse Index: a Nationwide Population-Based Study from Taiwan

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2020-10-152

OAAI

Assessing the Impact of Neighborhood Socioeconomic Characteristics on COVID-19 Prevalence Across Seven States in the United States

FRONTIERS IN PUBLIC HEALTH

IF3.4

2020-09-2261

OAAI

The Impact of Various Risk Assessment Time Frames on the Performance of Opioid Overdose Forecasting Models

IF2.8

2020-09-1011

PREAI

Association of Hypocalcemia and Magnesium Disorders With Thyroidectomy in Commercially Insured Patients

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY

IF5.6

2020-03-0117

OAAI

Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder

IF2.8

2019-09-015

PREAI

A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2019-08-0123

OAAI